Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: Worth the trouble

American Journal of Gastroenterology

Volumn 107, Issue 3, 2012, Pages 428-430

  Northup, Patrick G ^a   Henry, Zachary H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL; PROPRANOLOL;

ARTICLE; ASCITES; DEPRESSION; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; ESOPHAGUS VARICES; FATIGUE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROPHYLAXIS; SYNCOPE;

ADRENERGIC BETA-ANTAGONISTS; ASCITES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE;

EID: 84857862466     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.466     Document Type: Article

References (9)

1. Lebrec D, Nouel O, Bernuau J et al. Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet 1981; 1: 920-1. (Pubitemid 11096295)
2. Feu F, Garcia-Pagan JC, Bosch J et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-9.
3. Garcia-Tsao G, Groszmann RJ, Fisher RL et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-24. (Pubitemid 15065948)
4. Abraldes JG, Tarantino I, Turnes J et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 902-8. (Pubitemid 36397403)
5. Hernández-Gea V, Aracil C, Colomo A et al. Development of ascites in compensated cirrhosis with severe portal hypertension treated with betablockers. Am J Gastroenterol 2012; 107:418-27 (this issue).
6. D ' Amico G. Stages classification of cirrhosis: where do we stand? In: Portal Hypertension V. Proceedings of the Fift h Baveno International Consensus Workshop, Fift h Edition (ed: R de Franchis), Wiley-Blackwell, Oxford, UK, 2011; doi: 10.1002/9781444393989.ch12.
7. Garcia-Tsao G, Sanyal AJ, Grace ND et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38. (Pubitemid 47436138)
8. Groszmann RJ, Garcia-Tsao G, Bosch J et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 2254-61. (Pubitemid 41697288)
9. Lebrec D, Bernuau J, Rueff B et al. Gastrointestinal bleeding aft er abrupt cessation of propranolol administration in cirrhosis. N Engl J Med 1982; 307: 560. (Pubitemid 12038496)